New Immunotherapy Drugs Offer Even More Treatment Options & Hope for Lung Cancer Patients

New clinical trials here at The James offer even more hope and options for lung cancer patients, thanks to new immunotherapy drugs recently approved for lung cancer treatments. These drugs work with the body’s own immune system, and they maintain lower toxicity, frequent tumor shrinkage and long-lasting responses for patients.

And with new clinical trials researching their use in combination with other treatments, with surgery or, in some cases, even as the first treatment response for lung cancer, many patients are experiencing fewer side effects, shorter recovery times, and longer-lasting results.